Heres a quick breakdown of the differences between them: Tirzepatide combines the actions of two hormones : GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide)
You can use the same body area again, such as the stomach, but choose a different spot within that area
The standard titration schedule begins with 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks up to the target dose of 15 mg as tolerated
A Brief History of Tesofensine in Clinical Trials Tesofensines journey through clinical trials has been marked by both shifts in focus and encouraging results
Previous trials have demonstrated that GLP-1 RAs can reduce the risk of major adverse cardiovascular events (MACEs) and may have beneficial effects on kidney function 14,15,16,17
Follow with sunscreen during the day